They may offer a meaningful reduction in cravings and relapse risk across various addictive disorders." Dr Sophie Dix, Head of Medical Product and Content at Levity "GLP-1s appear to modulate activity in the mesolimbic dopamine system, the same circuitry implicated in both substance addiction and compulsive overeating
If you are reading this, there is a reasonable chance you are on one, or your doctor has raised it
Large studies showed it reduced major heart-related events by about 14% in people with type 2 diabetes
The Connection Many people continue to struggle with weight management even after their thyroid hormone levels are well controlled
Traditional Weight Loss Clinics Traditional in-person weight loss clinics often require frequent office visits, lengthy wait times for specialist appointments, and higher out-of-pocket costs - especially if insurance doesn't cover GLP-1 medications
The review traced the developmental history of GLP-1 research from the identification of the proglucagon gene in 1982 through to the contemporary landscape of GLP-1-based therapeutics across obesity, cardiovascular disease, NAFLD, neurodegeneration, and cancer biology